Pharmacy Chain 36.6 (MOEX:APTK)
Russia
· Delayed Price · Currency is RUB 12.50
-0.00 (-0.03%)
At close: Jul 8, 2022
Pharmacy Chain 36.6 Income Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 87,163 | 67,358 | 59,048 | 44,104 | 39,267 | Upgrade
| |
Revenue Growth (YoY) | 29.40% | 14.07% | 33.88% | 12.32% | 7.51% | Upgrade
|
Cost of Revenue | 59,027 | 45,319 | 39,049 | 29,147 | 25,860 | Upgrade
|
Gross Profit | 28,136 | 22,039 | 19,999 | 14,957 | 13,407 | Upgrade
|
Selling, General & Admin | 21,658 | 17,825 | 15,931 | 14,235 | 12,584 | Upgrade
|
Other Operating Expenses | -286 | -298 | -444 | -456 | -571 | Upgrade
|
Operating Expenses | 21,402 | 17,586 | 15,681 | 13,997 | 12,160 | Upgrade
|
Operating Income | 6,734 | 4,453 | 4,318 | 960 | 1,247 | Upgrade
|
Interest Expense | -6,578 | -4,140 | -4,241 | -3,239 | -4,634 | Upgrade
|
Interest & Investment Income | 346 | 283 | 391 | 412 | 83 | Upgrade
|
Currency Exchange Gain (Loss) | 9 | -45 | 14 | 30 | -202 | Upgrade
|
Other Non Operating Income (Expenses) | -324 | -251 | -251 | -212 | -181 | Upgrade
|
EBT Excluding Unusual Items | 187 | 300 | 231 | -2,049 | -3,687 | Upgrade
|
Gain (Loss) on Sale of Assets | -190 | -28 | 107 | -2 | 36 | Upgrade
|
Asset Writedown | 212 | -110 | 73 | 609 | 3,008 | Upgrade
|
Pretax Income | 209 | 162 | 411 | -1,442 | -643 | Upgrade
|
Income Tax Expense | -58 | 42 | 188 | -492 | 349 | Upgrade
|
Earnings From Continuing Operations | 267 | 120 | 223 | -950 | -992 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | 7,343 | Upgrade
|
Net Income to Company | 267 | 120 | 223 | -950 | 6,351 | Upgrade
|
Net Income | 267 | 120 | 223 | -950 | 6,351 | Upgrade
|
Net Income to Common | 267 | 120 | 223 | -950 | 6,351 | Upgrade
|
Net Income Growth | 122.50% | -46.19% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 7,576 | 7,617 | 7,630 | 7,630 | 6,807 | Upgrade
|
Shares Outstanding (Diluted) | 7,576 | 7,617 | 7,630 | 7,630 | 6,807 | Upgrade
|
Shares Change (YoY) | -0.54% | -0.17% | - | 12.11% | 39.36% | Upgrade
|
EPS (Basic) | 0.04 | 0.02 | 0.03 | -0.12 | 0.93 | Upgrade
|
EPS (Diluted) | 0.04 | 0.02 | 0.03 | -0.12 | 0.93 | Upgrade
|
EPS Growth | 123.72% | -46.10% | - | - | - | Upgrade
|
Free Cash Flow | 5,771 | 6,399 | 5,901 | 2,528 | -5,058 | Upgrade
|
Free Cash Flow Per Share | 0.76 | 0.84 | 0.77 | 0.33 | -0.74 | Upgrade
|
Gross Margin | 32.28% | 32.72% | 33.87% | 33.91% | 34.14% | Upgrade
|
Operating Margin | 7.73% | 6.61% | 7.31% | 2.18% | 3.18% | Upgrade
|
Profit Margin | 0.31% | 0.18% | 0.38% | -2.15% | 16.17% | Upgrade
|
Free Cash Flow Margin | 6.62% | 9.50% | 9.99% | 5.73% | -12.88% | Upgrade
|
EBITDA | 8,158 | 5,848 | 5,724 | 2,130 | 2,264 | Upgrade
|
EBITDA Margin | 9.36% | 8.68% | 9.69% | 4.83% | 5.77% | Upgrade
|
D&A For EBITDA | 1,424 | 1,395 | 1,406 | 1,170 | 1,017 | Upgrade
|
EBIT | 6,734 | 4,453 | 4,318 | 960 | 1,247 | Upgrade
|
EBIT Margin | 7.73% | 6.61% | 7.31% | 2.18% | 3.18% | Upgrade
|
Effective Tax Rate | - | 25.93% | 45.74% | - | - | Upgrade
|
Advertising Expenses | 441 | 543 | 368 | 213 | 166 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.